Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery

Biomaterials

Volumn 33, Issue 3, 2012, Pages 962-969

  Huang, Chaobo ^a   Soenen, Stefaan J ^a   van Gulck, Ellen ^b   Vanham, Guido ^b,c   Rejman, Joanna ^a   Van Calenbergh, Serge ^a   Vervaet, Chris ^a   Coenye, Tom ^a   Verstraelen, Hans ^d   Temmerman, Marleen ^d   Demeester, Jo ^a   De Smedt, Stefaan C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cellulose acetate phthalate; Drug delivery; Drug release; Electrospinning; HIV; Stimulus responsive polymer

Indexed keywords

ANTI-HIV; ANTI-MICROBIAL ACTIVITY; ANTI-VIRAL DRUGS; CELLULOSE ACETATE PHTHALATE; DRUG RELEASE; ELECTROSPINNING PROCESS; ELECTROSPUNS; ENCAPSULATED DRUGS; HIV; HIV TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS; IN-VITRO; MODERN MEDICINE; PH-DEPENDENT; RELEASE PROPERTY; VAGINAL DRUG DELIVERY;

BODY FLUIDS; CELLULOSE; DRUG DELIVERY; DRUG PRODUCTS; ELECTROSPINNING; ESTERS; FIBERS; VIRUSES; VOLATILE FATTY ACIDS;

DISEASES;

CELLACEFATE; ETRAVIRINE; TENOFOVIR DISOPROXIL;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSPINNING; ENCAPSULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PH; PRIORITY JOURNAL; SPERM; VAGINA DISCHARGE; VAGINA FLORA; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; ANTI-HIV AGENTS; CELL LINE; CELLULOSE; FEMALE; HUMANS; MALE; SEMEN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 81155137885     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.004     Document Type: Article

References (34)

1. HIV/AIDS disease and mortality in sub-Saharan Africa 2006, Washington (DC). D.T. Jamison, R.G. Feachem, M.W. Makgoba, E.R. Bos, F.K. Baingana, K.J. Hofman (Eds.).
2. Nyirjesy P. Chronic vulvovaginal candidiasis. Am Fam Physician 2001, 63:697-703.
3. Owen D.H., Katz D.F. A review of the properties of human semen and formulation of a semen simulant. J Androl 2005, 26:459-469.
4. AIDS Alert 2007, 22(Suppl. 1).
5. McCutchan F.E. Global epidemiology of HIV. J Med Virol 2006, 78:S7-S12.
6. Brenner B.G., Lowe M., Moisi D., Hardy I., Gagnon S., Charest H., et al. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors. J Med Virol 2011, 83:751-759.
7. Berger E.A., Doms R.W., Fenyo E.M., Korber B.T., Littman D.R., Moore J.P., et al. A new classification for HIV-1. Nature 1998, 391:240.
8. Neurath A.R., Strick N., Li Y.Y. Water dispersible microbicidal cellulose acetate phthalate film. Bmc Infect Dis 2003, 3:27.
9. das Neves J., Amiji M.M., Bahia M.F., Sarmento B. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. Adv Drug Deliver Rev 2010, 62:458-477.
10. Stone A., Jiang S.B. Microbicides: stopping HIV at the gate. Lancet 2006, 368:431-433.
11. Neurath A.R., Strick N., Jiang S.B., Li Y.Y., Debnath A.K. Anti-HIV-1 activity of cellulose acetate phthalate: Synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles. Bmc Infect Dis 2002, 2:6.
12. Rando R.F., Obara S., Osterling M.C., Mankowski M., Miller S.R., Ferguson M.L. Critical design features of phenyl carboxylate-containing polymer microbicides. Antimicrob Agents Chemother 2006, 50:3081-3089.
13. Tevi-Benissan C., Belec L., Levy M., Schneider-Fauveau V., Mohamed A.S., Hallouin M.C., et al. In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin Diagn Lab Immun 1997, 4:367-374.
14. Olaru N., Olaru L. Electrospinning of cellulose acetate phthalate from different solvent systems. Ind Eng Chem Res 2010, 49:1953-1957.
15. Owen D.H., Katz D.F. A vaginal fluid simulant. Contraception 1999, 59:91-95.
16. Hasselmann C. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 2003, 9.
17. Jay J.I., Lai B.E., Myszka D.G., Mahalingam A., Langheinrich K., Katz D.F., et al. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors. Mol Pharmacol 2010, 7:116-129.
18. Hummelen R., Fernandes A.D., Macklaim J.M., Dickson R.J., Changalucha J., Gloor G.B., et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010, 5:e12078.
19. Vasquez A., Jakobsson T., Ahrne S., Forsum U., Molin G. Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 2002, 40:2746-2749.
20. Nazli A., Chan O., Dobson-Belaire W.N., Ouellet M., Tremblay M.J., Gray-Owen S.D., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 2010, 6:e1000852.
21. Gallant J.E., Pham P.A. Tenofovir disoproxil fumarate for the treatment of HIV infection. Expert Opin Drug Metab Toxicol 2006, 2:459-469.
22. Van Herrewege Y., Vanham G., Michiels J., Fransen K., Kestens L., Andries K., et al. A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. Antimicrob Agents Chemother 2004, 48:3684-3689.
23. Di Fabio S., Van Roey J., Giannini G., van den Mooter G., Spada M., Binelli A., et al. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. Aids 2003, 17:1597-1604.
24. Rohan L.C., Sassi A.B. Vaginal drug delivery systems for HIV prevention. Aaps J 2009, 11:78-87.
25. Ham A.S., Cost M.R., Sassi A.B., Dezzutti C.S., Rohan L.C. Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Pharm Res 2009, 26:502-511.
26. Akashi M., Niikawa T., Serizawa T., Hayakawa T., Baba M. Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres. Bioconjug Chem 1998, 9:50-53.
27. Bowman M.C., Ballard T.E., Ackerson C.J., Feldheim D.L., Margolis D.M., Melander C. Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 2008, 130:6896-6897.
28. Malcolm R.K., Edwards K.L., Kiser P., Romano J., Smith T.J. Advances in microbicide vaginal rings. Antivir Res 2010, 88:S30-S39.
29. Gupta K.M., Barnes S.R., Tangaro R.A., Roberts M.C., Owen D.H., Katz D.F., et al. Temperature and semen sensitive hydrogels: an approach towards smart vaginal microbicide vehicles. J Pharm Sci-US 2007, 96:670-681.
30. Huang C., Soenen S.J., Rejman J., Lucas B., Braeckmans K., Demeester J., et al. Stimuli-responsive electrospun fibers and their applications. Chem Soc Rev 2011, 40:2417-2434.
31. Huang C., Lucas B., Vervaet C., Braeckmans K., Van Calenbergh S., Karalic I., et al. Unbreakable codes in electrospun fibers: digitally encoded polymers to stop medicine counterfeiting. Adv Mater 2010, 22:2657-2662.
32. Yu D.G., Branford-White C., Li L., Wu X.M., Zhu L.M. The compatibility of acyclovir with polyacrylonitrile in the electrospun drug-loaded nanofibers. J Appl Polym Sci 2010, 117:1509-1515.
33. Liu S.W., Lu H., Neurath A.R., Jiang S.B. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Antimicrob Agents Chemother 2005, 49:1830-1836.
34. Poveda E., Garrido C., de Mendoza C., Corral A., Cobo J., Gonzalez-Lahoz J., et al. Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors. J Antimicrob Chemother 2007, 60:1409-1410.